STOCK TITAN

Syros Pharmaceut (SYRS) Net Income by Year

SYRS

Syros Pharmaceut reported a net loss of $164.6M in fiscal year 2023. This represents a decrease of 73.9% from the prior fiscal year. Over the trailing 12 months, Q4 FY2023 through Q3 FY2024, the same line adds up to a $97.8M net loss. The table below carries 10 fiscal years, from 2014 to 2023, and the quarters Syros Pharmaceut has filed alongside them.

FY2023 annual
Net Income -$164.6M
YoY -73.9%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2024, ended Sep 30, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SYRS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Net Income-$97.8M-$164.6M-73.9%-$94.7M-9.4%-$86.6M-3.0%-$84.0M-11.5%-$75.4M-21.0%-$62.3M-15.4%-$54.0M-13.2%-$47.7M-60.1%-$29.8M-122.4%-$13.4M

TTM is the trailing twelve months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings.

SYRS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-QQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-K
Net Income-$6.4M+84.1%-$23.3M+35.7%-$3.7M+84.4%-$64.4M-$40.1M-32.7%-$36.3M-5.2%-$23.8M+5.4%N/A-$30.3M-16.2%-$34.5M-53.3%-$25.1M-76.7%-$23.8M+21.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Syros Pharmaceut financials

Frequently Asked Questions

What was Syros Pharmaceut's net income in fiscal year 2023?

Syros Pharmaceut reported a net loss of $164.6M in fiscal year 2023.

How fast is Syros Pharmaceut's net income growing?

Syros Pharmaceut (SYRS) net income fell by 73.9% year over year, from -$94.7M to -$164.6M in fiscal year 2023.

What is Syros Pharmaceut's net income over the last twelve months?

Syros Pharmaceut (SYRS) reported a $97.8M net loss over the trailing 12 months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings.

Across the 10 fiscal years this page covers, Syros Pharmaceut (SYRS) net income went from -$13.4M in fiscal year 2014 to -$164.6M in fiscal year 2023.

Syros Pharmaceut (SYRS) reported -$6.4M in net income in Q3 2024. This represents an increase of 84.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Syros Pharmaceut (SYRS) reported on that line in every period on record.